Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to $187000.0.

  • Celularity's Change in Account Payables fell 8905.79% to $187000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.2 million, marking a year-over-year increase of 20173.49%. This contributed to the annual value of $9.2 million for FY2024, which is 873.25% up from last year.
  • Celularity's Change in Account Payables amounted to $187000.0 in Q3 2025, which was down 8905.79% from $1.1 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Change in Account Payables ranged from a high of $7.9 million in Q4 2024 and a low of -$3.2 million during Q4 2022
  • Over the past 5 years, Celularity's median Change in Account Payables value was $775000.0 (recorded in 2024), while the average stood at $1.0 million.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 203376.62% in 2021, then plummeted by 29750.46% in 2022.
  • Celularity's Change in Account Payables (Quarter) stood at $1.6 million in 2021, then crashed by 297.5% to -$3.2 million in 2022, then skyrocketed by 153.71% to $1.7 million in 2023, then soared by 354.79% to $7.9 million in 2024, then crashed by 97.64% to $187000.0 in 2025.
  • Its Change in Account Payables stands at $187000.0 for Q3 2025, versus $1.1 million for Q2 2025 and $17000.0 for Q1 2025.